Request for Covid-19 Impact Assessment of this Report
Market Segmentation:
By Type (Assays, Devices, Consumables), Disease Type (Type 1 Diabetes, Type 2 Diabetes, Gestational Diabetes), Deployment (Automated, Manual), End User (Hospitals, Clinics, Diagnostic Laboratories, Academic Institutes, Others), Distribution Channel (Direct, Indirect), Country (China, Japan, India, South Korea, Australia, Malaysia, Singapore, Thailand, Indonesia, Philippines and Rest of Asia-Pacific)
Some of the major factors contributing to the growth of the market are:
• Availability of reimbursement in the developing countries
• Rising cases of diabetes
Market Players:
The key market players for Asia-Pacific diabetic assays market are listed below:
• Abbott
• Danaher
• Merck KGaA
• SIEMENS HEALTHINEERS AG
• Bio-Rad Laboratories, Inc.
• DiaSorin S.p.A.
• EKF Diagnostics
• DRG INSTRUMENTS GMBH
• PTS Diagnostics
• Ortho Clinical Diagnostics
• Medipan GmbH
• Diagnostic Automation/Cortez Diagnostics Inc.
• Diazyme Laboratories, Inc.
• Ethos Biosciences, Inc.
• BioAssay Systems
• Tosoh Corporation
• Abnova Corporation
• Monobind Inc
• ORGENTEC Diagnostika GmbH
• ALPCO
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF ASIA-PACIFIC DIABETIC ASSAYS MARKET
1.4 LIMITATIONS
1.5 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 MARKETS COVERED
2.2 GEOGRAPHICAL SCOPE
2.3 YEARS CONSIDERED FOR THE STUDY
2.4 CURRENCY AND PRICING
2.5 DBMR TRIPOD DATA VALIDATION MODEL
2.6 MULTIVARIATE MODELLING
2.7 PRODUCTS LIFELINE CURVE
2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.9 DBMR MARKET POSITION GRID
2.10 VENDOR SHARE ANALYSIS
2.11 SECONDARY SOURCES
2.12 ASSUMPTIONS
3 MARKET OVERVIEW
3.1 DRIVERS
3.1.1 INCREASING PREVALENCE OF DIABETES
3.1.2 INCREASING GERIATRIC POPULATION
3.1.3 TECHNOLOGICAL ADVANCEMENT
3.1.4 AVAILABILITY OF REIMBURSEMENT
3.1.5 INCREASING DEMAND FOR THE HAND-HELD DIAGNOSTIC DEVICES
3.2 RESTRAINT
3.2.1 PRODUCT RECALL
3.2.2 HIGH COST OF THE ASSAY
3.2.3 IMPLEMENTATION OF EXCISE DUTY BY THE U.S. GOVERNMENT
3.3 OPPORTUNITIES
3.3.1 RISING GOVERNMENT INITIATIVES
3.3.2 STRATEGIC INITIATIVE BY MARKET PLAYERS
3.3.3 RISE IN AWARENESS AMONG THE POPULATION
3.3.4 GROWING HEALTHCARE INFRASTRUCTURE
3.4 CHALLENGES
3.4.1 STRINGENT REGULATION
3.4.2 LACK OF SKILLED PROFESSIONALS
3.4.3 LOW PENETRATION IN DEVELOPING ECONOMIES
4 EXECUTIVE SUMMARY
5 PREMIUM INSIGHTS
6 REGULATORY PROCEDURE
7 ASIA-PACIFIC DIABETIC ASSAYS MARKET, BY TYPE
7.1 OVERVIEW
7.2 ASSAYS
7.2.1 DIABETES DIAGNOSTICS GLUCOSE ASSAY
7.2.2 DIABETES DIAGNOSTICS HBA1C ASSAY
7.3 DEVICES
7.3.1 ANALYZERS
7.3.2 SOFTWARE
7.4 CONSUMABLES
7.4.1 TEST STRIPS
7.4.2 REAGENT
7.4.3 OTHERS
8 ASIA-PACIFIC DIABETIC ASSAYS MARKET, BY DISEASE TYPE
8.1 OVERVIEW
8.2 TYPE 2 DIABETES
8.3 TYPE 1 DIABETES
8.4 GESTATIONAL DIABETES
9 ASIA-PACIFIC DIABETIC ASSAYS MARKET, BY DEPLOYMENT
9.1 OVERVIEW
9.2 AUTOMATED
9.3 MANUAL
10 ASIA-PACIFIC DIABETIC ASSAYS MARKET, BY END USER
10.1 OVERVIEW
10.2 HOSPITALS
10.3 DIAGNOSTIC LABORATORIES
10.4 CLINICS
10.5 ACADEMIC INSTITUTES
10.6 OTHERS
11 ASIA-PACIFIC DIABETIC ASSAYS MARKET, BY DISTRIBUTION CHANNEL
11.1 OVERVIEW
11.2 DIRECT
11.3 INDIRECT
12 ASIA-PACIFIC DIABETIC ASSAYS MARKET, BY GEOGRAPHY
12.1 ASIA-PACIFIC
12.1.1 CHINA
12.1.2 JAPAN
12.1.3 INDIA
12.1.4 SOUTH KOREA
12.1.5 AUSTRALIA
12.1.6 MALAYSIA
12.1.7 SINGAPORE
12.1.8 THAILAND
12.1.9 INDONESIA
12.1.10 PHILIPPINES
12.1.11 REST OF ASIA-PACIFIC
13 ASIA-PACIFIC DIABETIC ASSAYS MARKET, COMPANY LANDSCAPE
13.1 COMPANY SHARE ANALYSIS: ASIA-PACIFIC
14 COMPANY PROFILE
14.1 BIO-RAD LABORATORIES, INC.
14.1.1 COMPANY SNAPSHOT
14.1.2 REVENUE ANALYSIS
14.1.3 COMPANY SHARE ANALYSIS
14.1.4 PRODUCT PORTFOLIO
14.1.5 RECENT DEVELOPMENT
14.2 ABBOTT
14.2.1 COMPANY SNAPSHOT
14.2.2 REVENUE ANALYSIS
14.2.3 COMPANY SHARE ANALYSIS
14.2.4 PRODUCT PORTFOLIO
14.2.5 RECENT DEVELOPMENT
14.3 SIEMENS HEALTHINEERS AG
14.3.1 COMPANY SNAPSHOT
14.3.2 REVENUE ANALYSIS
14.3.3 COMPANY SHARE ANALYSIS
14.3.4 PRODUCT PORTFOLIO
14.3.5 RECENT DEVELOPMENT
14.4 DANAHER
14.4.1 COMPANY SNAPSHOT
14.4.2 REVENUE ANALYSIS
14.4.3 COMPANY SHARE ANALYSIS
14.4.4 PRODUCT PORTFOLIO
14.4.5 RECENT DEVELOPMENT
14.5 DIASORIN S.P.A.
14.5.1 COMPANY SNAPSHOT
14.5.2 REVENUE ANALYSIS
14.5.3 COMPANY SHARE ANALYSIS
14.5.4 PRODUCT PORTFOLIO
14.5.5 RECENT DEVELOPMENT
14.6 ABNOVA CORPORATION
14.6.1 COMPANY SNAPSHOT
14.6.2 PRODUCT PORTFOLIO
14.6.3 RECENT DEVELOPMENT
14.7 ALPCO
14.7.1 COMPANY SNAPSHOT
14.7.2 PRODUCT PORTFOLIO
14.7.3 RECENT DEVELOPMENTS
14.8 BIOASSAY SYSTEMS
14.8.1 COMPANY SNAPSHOT
14.8.2 PRODUCT PORTFOLIO
14.8.3 RECENT DEVELOPMENT
14.9 DIAGNOSTIC AUTOMATION/CORTEZ DIAGNOSTICS INC.
14.9.1 COMPANY SNAPSHOT
14.9.2 PRODUCT PORTFOLIO
14.9.3 RECENT DEVELOPMENT
14.10 DIAZYME LABORATORIES, INC.
14.10.1 COMPANY SNAPSHOT
14.10.2 PRODUCT PORTFOLIO
14.10.3 RECENT DEVELOPMENTS
14.11 DRG INSTRUMENTS GMBH
14.11.1 COMPANY SNAPSHOT
14.11.2 PRODUCT PORTFOLIO
14.11.3 RECENT DEVELOPMENT
14.12 EKF DIAGNOSTICS HOLDINGS PLC
14.12.1 COMPANY SNAPSHOT
14.12.2 REVENUE ANALYSIS
14.12.3 PRODUCT PORTFOLIO
14.12.4 RECENT DEVELOPMENT
14.13 ETHOS BIOSCIENCES, INC.
14.13.1 COMPANY SNAPSHOT
14.13.2 PRODUCT PORTFOLIO
14.13.3 RECENT DEVELOPMENT
14.14 MEDIPAN GMBH
14.14.1 COMPANY SNAPSHOT
14.14.2 PRODUCT PORTFOLIO
14.14.3 RECENT DEVELOPMENT
14.15 MERCK KGAA
14.15.1 COMPANY SNAPSHOT
14.15.2 REVENUE ANALYSIS
14.15.3 PRODUCT PORTFOLIO
14.15.4 RECENT DEVELOPMENT
14.16 MONOBIND INC.
14.16.1 COMPANY SNAPSHOT
14.16.2 PRODUCT PORTFOLIO
14.16.3 RECENT DEVELOPMENT
14.17 ORGENTEC DIAGNOSTIKA GMBH
14.17.1 COMPANY SNAPSHOT
14.17.2 PRODUCT PORTFOLIO
14.17.3 RECENT DEVELOPMENT
14.18 ORTHO CLINICAL DIAGNOSTICS
14.18.1 COMPANY SNAPSHOT
14.18.2 PRODUCT PORTFOLIO
14.18.3 RECENT DEVELOPMENT
14.19 PTS DIAGNOSTICS (A SUBSIDIARY OF SANNUO BIOSENSOR CO., LTD.)
14.19.1 COMPANY SNAPSHOT
14.19.2 PRODUCT PORTFOLIO
14.19.3 RECENT DEVELOPMENT
14.20 TOSOH CORPORATION
14.20.1 COMPANY SNAPSHOT
14.20.2 REVENUE ANALYSIS
14.20.3 PRODUCT PORTFOLIO
14.20.4 RECENT DEVELOPMENT
15 QUESTIONNAIRE
16 RELATED REPORTS
TABLE 1 CANADA REIMBURSEMENT LIMITS FOR TEST STRIPS FOR EACH 365-DAY PERIOD
TABLE 2 IRELAND REIMBURSEMENT FOR TEST STRIPS
TABLE 3 COMPARISON OF NGSP-CERTIFIED A1C POC DEVICES
TABLE 4 MEDICAL DEVICE RECALLS
TABLE 5 BIO-RAD LABORATORIES, INC. (U.S.) DIABETIC ASSAYS PRICES
TABLE 6 PRIVATE-SECTOR R&D INVESTMENT IN MEDICAL DEVICES AND EQUIPMENT ( IN USD MILLION)
TABLE 7 HEALTHCARE EXPENDITURE IN ASIA-PACIFIC
TABLE 8 DIRECT COSTS OF DIABETES (IN USD)
TABLE 9 ASIA-PACIFIC DIABETIC ASSAYS MARKET, BY TYPE, 2018–2027 (USD MILLION)
TABLE 10 ASIA-PACIFIC ASSAYS DIABETIC ASSAYS MARKET, BY REGION, 2018-2027 (USD MILLION)
TABLE 11 ASIA-PACIFIC ASSAYS IN DIABETIC ASSAYS MARKET, BY TYPE, 2018–2027 (USD MILLION)
TABLE 12 ASIA-PACIFIC DEVICES IN DIABETIC ASSAYS MARKET, BY REGION, 2018-2027 (USD MILLION)
TABLE 13 ASIA-PACIFIC DEVICES IN DIABETIC ASSAYS MARKET, BY TYPE, 2018–2027 (USD MILLION)
TABLE 14 ASIA-PACIFIC CONSUMABLES IN DIABETIC ASSAYS MARKET, BY REGION, 2018-2027 (USD MILLION)
TABLE 15 ASIA-PACIFIC CONSUMABLES IN DIABETIC ASSAYS MARKET, BY TYPE, 2018–2027 (USD MILLION)
TABLE 16 ASIA-PACIFIC DIABETIC ASSAYS MARKET, BY DISEASE TYPE, 2018-2027 (USD MILLION)
TABLE 17 ASIA-PACIFIC TYPE 2 DIABETES DIABETIC ASSAYS MARKET, BY REGION, 2018-2027 (USD MILLION)
TABLE 18 ASIA-PACIFIC TYPE 1 DIABETES IN DIABETIC ASSAYS MARKET, BY REGION, 2018-2027 (USD MILLION)
TABLE 19 ASIA-PACIFIC GESTATIONAL DIABETES IN DIABETIC ASSAYS MARKET, BY REGION, 2018-2027 (USD MILLION)
TABLE 20 ASIA-PACIFIC DIABETIC ASSAYS MARKET, BY DEPLOYMENT, 2018-2027 (USD MILLION)
TABLE 21 ASIA-PACIFIC AUTOMATED IN DIABETIC ASSAYS MARKET, BY REGION, 2018-2027 (USD MILLION)
TABLE 22 ASIA-PACIFIC MANUAL IN DIABETIC ASSAYS MARKET, BY REGION, 2018-2027 (USD MILLION)
TABLE 23 ASIA-PACIFIC DIABETIC ASSAYS MARKET, BY END USER, 2018-2027 (USD MILLION)
TABLE 24 ASIA-PACIFIC HOSPITALS IN DIABETIC ASSAYS MARKET, BY REGION, 2018-2027 (USD MILLION)
TABLE 25 ASIA-PACIFIC DIAGNOSTIC LABORATORIES IN DIABETIC ASSAYS MARKET, BY REGION, 2018-2027 (USD MILLION)
TABLE 26 ASIA-PACIFIC CLINICS IN DIABETIC ASSAYS MARKET, BY REGION, 2018-2027 (USD MILLION)
TABLE 27 ASIA-PACIFIC ACADEMIC INSTITUTES IN DIABETIC ASSAYS MARKET, BY REGION, 2018-2027 (USD MILLION)
TABLE 28 ASIA-PACIFIC OTHERS IN DIABETIC ASSAYS MARKET, BY REGION, 2018-2027 (USD MILLION)
TABLE 29 ASIA-PACIFIC DIABETIC ASSAYS MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)
TABLE 30 ASIA-PACIFIC DIRECT IN DIABETIC ASSAYS MARKET, BY REGION, 2018-2027 (USD MILLION)
TABLE 31 ASIA-PACIFIC INDIRECT IN DIABETIC ASSAYS MARKET, BY REGION, 2018-2027 (USD MILLION)
TABLE 32 ASIA-PACIFIC DIABETIC ASSAYS MARKET, BY COUTRY, 2018-2027 (USD MILLION))
TABLE 33 ASIA-PACIFIC DIABETIC ASSAYS MARKET, BY TYPE, 2018-2027 (USD MILLION)
TABLE 34 ASIA-PACIFIC DEVICES IN DIABETIC ASSAYS MARKET, BY TYPE, 2018-2027 (USD MILLION)
TABLE 35 ASIA-PACIFIC ASSAYS IN DIABETIC ASSAYS MARKET, BY TYPE, 2018-2027 (USD MILLION)
TABLE 36 ASIA-PACIFIC CONSUMABLES IN DIABETIC ASSAYS MARKET, BY TYPE, 2018-2027 (USD MILLION)
TABLE 37 ASIA-PACIFIC DIABETIC ASSAYS MARKET, BY DISEASE TYPE, 2018-2027 (USD MILLION)
TABLE 38 ASIA-PACIFIC DIABETIC ASSAYS MARKET, BY DEPLOYMENT, 2018-2027 (USD MILLION)
TABLE 39 ASIA-PACIFIC DIABETIC ASSAYS MARKET, BY END USER, 2018-2027 (USD MILLION)
TABLE 40 ASIA-PACIFIC DIABETIC ASSAYS MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)
TABLE 41 CHINA DIABETIC ASSAYS MARKET, BY TYPE, 2018-2027 (USD MILLION)
TABLE 42 CHINA DEVICES IN DIABETIC ASSAYS MARKET, BY TYPE, 2018-2027 (USD MILLION)
TABLE 43 CHINA ASSAYS IN DIABETIC ASSAYS MARKET, BY TYPE, 2018-2027 (USD MILLION)
TABLE 44 CHINA CONSUMABLES IN DIABETIC ASSAYS MARKET, BY TYPE, 2018-2027 (USD MILLION)
TABLE 45 CHINA DIABETIC ASSAYS MARKET, BY DISEASE TYPE, 2018-2027 (USD MILLION)
TABLE 46 CHINA DIABETIC ASSAYS MARKET, BY DEPLOYMENT, 2018-2027 (USD MILLION)
TABLE 47 CHINA DIABETIC ASSAYS MARKET, BY END USER, 2018-2027 (USD MILLION)
TABLE 48 CHINA DIABETIC ASSAYS MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)
TABLE 49 JAPAN DIABETIC ASSAYS MARKET, BY TYPE, 2018-2027 (USD MILLION)
TABLE 50 JAPAN DEVICES IN DIABETIC ASSAYS MARKET, BY TYPE, 2018-2027 (USD MILLION)
TABLE 51 JAPAN ASSAYS IN DIABETIC ASSAYS MARKET, BY TYPE, 2018-2027 (USD MILLION)
TABLE 52 JAPAN CONSUMABLES IN DIABETIC ASSAYS MARKET, BY TYPE, 2018-2027 (USD MILLION)
TABLE 53 JAPAN DIABETIC ASSAYS MARKET, BY DISEASE TYPE, 2018-2027 (USD MILLION)
TABLE 54 JAPAN DIABETIC ASSAYS MARKET, BY DEPLOYMENT, 2018-2027 (USD MILLION)
TABLE 55 JAPAN DIABETIC ASSAYS MARKET, BY END USER, 2018-2027 (USD MILLION)
TABLE 56 JAPAN DIABETIC ASSAYS MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)
TABLE 57 INDIA DIABETIC ASSAYS MARKET, BY TYPE, 2018-2027 (USD MILLION)
TABLE 58 INDIA DEVICES IN DIABETIC ASSAYS MARKET, BY TYPE, 2018-2027 (USD MILLION)
TABLE 59 INDIA ASSAYS IN DIABETIC ASSAYS MARKET, BY TYPE, 2018-2027 (USD MILLION)
TABLE 60 INDIA CONSUMABLES IN DIABETIC ASSAYS MARKET, BY TYPE, 2018-2027 (USD MILLION)
TABLE 61 INDIA DIABETIC ASSAYS MARKET, BY DISEASE TYPE, 2018-2027 (USD MILLION)
TABLE 62 INDIA DIABETIC ASSAYS MARKET, BY DEPLOYMENT, 2018-2027 (USD MILLION)
TABLE 63 INDIA DIABETIC ASSAYS MARKET, BY END USER, 2018-2027 (USD MILLION)
TABLE 64 INDIA DIABETIC ASSAYS MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)
TABLE 65 SOUTH KOREA DIABETIC ASSAYS MARKET, BY TYPE, 2018-2027 (USD MILLION)
TABLE 66 SOUTH KOREA DEVICES IN DIABETIC ASSAYS MARKET, BY TYPE, 2018-2027 (USD MILLION)
TABLE 67 SOUTH KOREA ASSAYS IN DIABETIC ASSAYS MARKET, BY TYPE, 2018-2027 (USD MILLION)
TABLE 68 SOUTH KOREA CONSUMABLES IN DIABETIC ASSAYS MARKET, BY TYPE, 2018-2027 (USD MILLION)
TABLE 69 SOUTH KOREA DIABETIC ASSAYS MARKET, BY DISEASE TYPE, 2018-2027 (USD MILLION)
TABLE 70 SOUTH KOREA DIABETIC ASSAYS MARKET, BY DEPLOYMENT, 2018-2027 (USD MILLION)
TABLE 71 SOUTH KOREA DIABETIC ASSAYS MARKET, BY END USER, 2018-2027 (USD MILLION)
TABLE 72 SOUTH KOREA DIABETIC ASSAYS MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)
TABLE 73 AUSTRALIA DIABETIC ASSAYS MARKET, BY TYPE, 2018-2027 (USD MILLION)
TABLE 74 AUSTRALIA DEVICES IN DIABETIC ASSAYS MARKET, BY TYPE, 2018-2027 (USD MILLION)
TABLE 75 AUSTRALIA ASSAYS IN DIABETIC ASSAYS MARKET, BY TYPE, 2018-2027 (USD MILLION)
TABLE 76 AUSTRALIA CONSUMABLES IN DIABETIC ASSAYS MARKET, BY TYPE, 2018-2027 (USD MILLION)
TABLE 77 AUSTRALIA DIABETIC ASSAYS MARKET, BY DISEASE TYPE, 2018-2027 (USD MILLION)
TABLE 78 AUSTRALIA DIABETIC ASSAYS MARKET, BY DEPLOYMENT, 2018-2027 (USD MILLION)
TABLE 79 AUSTRALIA DIABETIC ASSAYS MARKET, BY END USER, 2018-2027 (USD MILLION)
TABLE 80 AUSTRALIA DIABETIC ASSAYS MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)
TABLE 81 MALAYSIA DIABETIC ASSAYS MARKET, BY TYPE, 2018-2027 (USD MILLION)
TABLE 82 MALAYSIA DEVICES IN DIABETIC ASSAYS MARKET, BY TYPE, 2018-2027 (USD MILLION)
TABLE 83 MALAYSIA ASSAYS IN DIABETIC ASSAYS MARKET, BY TYPE, 2018-2027 (USD MILLION)
TABLE 84 MALAYSIA CONSUMABLES IN DIABETIC ASSAYS MARKET, BY TYPE, 2018-2027 (USD MILLION)
TABLE 85 MALAYSIA DIABETIC ASSAYS MARKET, BY DISEASE TYPE, 2018-2027 (USD MILLION)
TABLE 86 MALAYSIA DIABETIC ASSAYS MARKET, BY DEPLOYMENT, 2018-2027 (USD MILLION)
TABLE 87 MALAYSIA DIABETIC ASSAYS MARKET, BY END USER, 2018-2027 (USD MILLION)
TABLE 88 MALAYSIA DIABETIC ASSAYS MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)
TABLE 89 SINGAPORE DIABETIC ASSAYS MARKET, BY TYPE, 2018-2027 (USD MILLION)
TABLE 90 SINGAPORE DEVICES IN DIABETIC ASSAYS MARKET, BY TYPE, 2018-2027 (USD MILLION)
TABLE 91 SINGAPORE ASSAYS IN DIABETIC ASSAYS MARKET, BY TYPE, 2018-2027 (USD MILLION)
TABLE 92 SINGAPORE CONSUMABLES IN DIABETIC ASSAYS MARKET, BY TYPE, 2018-2027 (USD MILLION)
TABLE 93 SINGAPORE DIABETIC ASSAYS MARKET, BY DISEASE TYPE, 2018-2027 (USD MILLION)
TABLE 94 SINGAPORE DIABETIC ASSAYS MARKET, BY DEPLOYMENT, 2018-2027 (USD MILLION)
TABLE 95 SINGAPORE DIABETIC ASSAYS MARKET, BY END USER, 2018-2027 (USD MILLION)
TABLE 96 SINGAPORE DIABETIC ASSAYS MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)
TABLE 97 THAILAND DIABETIC ASSAYS MARKET, BY TYPE, 2018-2027 (USD MILLION)
TABLE 98 THAILAND DEVICES IN DIABETIC ASSAYS MARKET, BY TYPE, 2018-2027 (USD MILLION)
TABLE 99 THAILAND ASSAYS IN DIABETIC ASSAYS MARKET, BY TYPE, 2018-2027 (USD MILLION)
TABLE 100 THAILAND CONSUMABLES IN DIABETIC ASSAYS MARKET, BY TYPE, 2018-2027 (USD MILLION)
TABLE 101 THAILAND DIABETIC ASSAYS MARKET, BY DISEASE TYPE, 2018-2027 (USD MILLION)
TABLE 102 THAILAND DIABETIC ASSAYS MARKET, BY DEPLOYMENT, 2018-2027 (USD MILLION)
TABLE 103 THAILAND DIABETIC ASSAYS MARKET, BY END USER, 2018-2027 (USD MILLION)
TABLE 104 THAILAND DIABETIC ASSAYS MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)
TABLE 105 INDONESIA DIABETIC ASSAYS MARKET, BY TYPE, 2018-2027 (USD MILLION)
TABLE 106 INDONESIA DEVICES IN DIABETIC ASSAYS MARKET, BY TYPE, 2018-2027 (USD MILLION)
TABLE 107 INDONESIA ASSAYS IN DIABETIC ASSAYS MARKET, BY TYPE, 2018-2027 (USD MILLION)
TABLE 108 INDONESIA CONSUMABLES IN DIABETIC ASSAYS MARKET, BY TYPE, 2018-2027 (USD MILLION)
TABLE 109 INDONESIA DIABETIC ASSAYS MARKET, BY DISEASE TYPE, 2018-2027 (USD MILLION)
TABLE 110 INDONESIA DIABETIC ASSAYS MARKET, BY DEPLOYMENT, 2018-2027 (USD MILLION)
TABLE 111 INDONESIA DIABETIC ASSAYS MARKET, BY END USER, 2018-2027 (USD MILLION)
TABLE 112 INDONESIA DIABETIC ASSAYS MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)
TABLE 113 PHILIPPINES DIABETIC ASSAYS MARKET, BY TYPE, 2018-2027 (USD MILLION)
TABLE 114 PHILIPPINES DEVICES IN DIABETIC ASSAYS MARKET, BY TYPE, 2018-2027 (USD MILLION)
TABLE 115 PHILIPPINES ASSAYS IN DIABETIC ASSAYS MARKET, BY TYPE, 2018-2027 (USD MILLION)
TABLE 116 PHILIPPINES CONSUMABLES IN DIABETIC ASSAYS MARKET, BY TYPE, 2018-2027 (USD MILLION)
TABLE 117 PHILIPPINES DIABETIC ASSAYS MARKET, BY DISEASE TYPE, 2018-2027 (USD MILLION)
TABLE 118 PHILIPPINES DIABETIC ASSAYS MARKET, BY DEPLOYMENT, 2018-2027 (USD MILLION)
TABLE 119 PHILIPPINES DIABETIC ASSAYS MARKET, BY END USER, 2018-2027 (USD MILLION)
TABLE 120 PHILIPPINES DIABETIC ASSAYS MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)
TABLE 121 REST OF ASIA-PACIFIC DIABETIC ASSAYS MARKET, BY TYPE, 2018-2027 (USD MILLION)
The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...
The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...
The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...